Functional Expression of Sodium Iodide Symporter (NIS) in Human Breast Cancer Tissue

By Upadhyay G.  

Breast Cancer Research and Treatment, Vol. 77, Iss. 2, 2003-01 ,pp. : 157-165

Springer Publishing Company

Access to resources Recommend Favorite

Effect of sodium/iodide symporter (NIS)-mediated radioiodine therapy on estrogen receptor-negative breast cancer

By              

Oncology Reports, Vol. 34, Iss. 1, 2015-01 ,pp. : 59-66

Spandidos Publications

Access to resources Recommend Favorite

Stimulation of retinoic acid-induced functional sodium iodide symporter (NIS) expression and cytotoxicity of ¹³¹I by carbamazepine in breast cancer cells

By Willhauck Michael   O`Kane Dennis   Wunderlich Nathalie   Göke Burkhard   Spitzweg Christine  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 377-386

Springer Publishing Company

Access to resources Recommend Favorite

The pan-histone deacetylase inhibitor LBH589 (panobinostat) alters the invasive breast cancer cell phenotype

By            

International Journal of Oncology, Vol. 44, Iss. 3, 2014-01 ,pp. : 700-708

Spandidos Publications

Access to resources Recommend Favorite

Reduction in clonogenic survival of sodium-iodide symporter (NIS)-positive cells following intracellular uptake of ^99mTc versus ¹⁸⁸Re

By Freudenberg Robert   Wendisch Maria   Runge Roswitha   Wunderlich Gerd   Kotzerke Jörg  

International Journal of Radiation Biology, Vol. 88, Iss. 12, 2012-12 ,pp. : 991-997

Informa Healthcare

Access to resources Recommend Favorite